Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Blinatumomab (formerly known as Anatumomab) is a bispecific monoclonal antibody that specifically targets the CD19 antigen on B cells and is utilized in the study of acute lymphoblastic leukemia [1].
説明 | Blinatumomab (formerly known as Anatumomab) is a bispecific monoclonal antibody that specifically targets the CD19 antigen on B cells and is utilized in the study of acute lymphoblastic leukemia [1]. |
別名 | Anatumomab |
分子量 | N/A |
CAS No. | 853426-35-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Blinatumomab 853426-35-4 Anatumomab Inhibitor inhibitor inhibit